Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | DAL | Common Stock | 30.6K | Jan 1, 2025 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | DAL | Employee Stock Option (right to buy) | Jan 1, 2025 | Common Stock | 13.9K | $50.52 | Direct | F2 | ||||||
holding | DAL | Employee Stock Option (right to buy) | Jan 1, 2025 | Common Stock | 13.5K | $58.89 | Direct | F3 | ||||||
holding | DAL | Employee Stock Option (right to buy) | Jan 1, 2025 | Common Stock | 9.08K | $39.78 | Direct | F4 |
Id | Content |
---|---|
F1 | Includes 27,160 shares of restricted common stock. Of these restricted shares: (i) 4,180 were granted to the Reporting Person on February 9, 2022 and will vest on February 1, 2025, (ii) 9,300 were granted to the Reporting Person on February 8, 2023 and will vest in two equal installments on February 1, 2025 and 2026, and (iii) 13,680 were granted to the Reporting Person on February 7, 2024 and will vest in three equal installments on February 1, 2025, 2026 and 2027. The grants of restricted stock were approved by the Personnel & Compensation Committee ("P&C Committee") of Delta's Board of Directors and are exempt from Section 16(b) of the Securities Exchange Act of 1934 ("Exchange Act") under Rule 16b-3(d)(1). |
F2 | On February 6, 2019, the P&C Committee granted the Reporting Person an option to purchase 13,880 shares of common stock. The option vested subject to Delta's satisfaction of certain performance criteria, which were certified by the P&C Committee on February 5, 2020. This grant was approved by the P&C Committee and is exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d)(1). |
F3 | On February 5, 2020, the P&C Committee granted the Reporting Person an option to purchase 13,460 shares of common stock. The option vested subject to Delta's satisfaction of certain performance criteria, which were certified by the P&C Committee on February 9, 2022. This grant was approved by the P&C Committee and is exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d)(1). |
F4 | On February 3, 2021, the P&C Committee granted the Reporting Person an option to purchase 9,080 shares of common stock under the 2021 long-term incentive program. The option vested in three equal installments on February 1, 2022, 2023 and 2024. This grant was approved by the P&C Committee and is exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d)(1). |
Exhibit 24 - Power of Attorney